申请人:Biothera, Inc.
公开号:US20140228543A1
公开(公告)日:2014-08-14
Modified and/or derivativized β-glucans with an enhanced capacity to modulate human immune response as compared to the parent, unmodified and/or underivatized β-glucans are demonstrated.
改性和/或衍生的β-
葡聚糖表现出比未改性和/或未衍生的β-
葡聚糖更强的调节人类免疫反应的能力。